Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
Aastrom Biosciences, Inc. (NASDAQ: ASTM)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Premium News
Press Releases
SEC
Rothman Research Follow-up Study of Charles Schwab Corp., SIRIUS XM Radio Inc., Aastrom Biosciences Inc., Sonic Corp., Zhone Technologies Inc. and United Community Banks Inc.
Nov 20, 2009 07:58 AM |
ASTM
,
SONC
,
UCBI
,
ZHNE
Updates and Results From Aastrom's Vascular Program Presented at an American Heart Association Satellite Symposium
Nov 16, 2009 06:56 AM |
ASTM
Interim Results From Aastrom's IMPACT-DCM Cardiac Trial Presented at The American Heart Association Meeting
Nov 16, 2009 06:51 AM |
ASTM
Trading Outlook for Hard To Treat Diseases Inc. Issued by InvestorSoup.com
Nov 13, 2009 06:51 AM |
ASTM
,
CYPB
,
INO
Aastrom to Initiate Second Phase II Clinical Trial for Treatment of Severe Chronic Heart Failure
Nov 10, 2009 01:31 PM |
ASTM
Aastrom Biosciences Reports First Quarter Fiscal Year 2010 Financial Results
Nov 06, 2009 01:31 PM |
ASTM
Integrity Media: Stem Cell Report Released
Oct 30, 2009 10:01 AM |
ASTM
,
OSIR
RidgewaterEquity.com Free Fundamental Sector & Market Research on SGMS, STX, ARRS, SCHW, ASTM and MDCO
Oct 30, 2009 06:23 AM |
ARRS
,
ASTM
,
SGMS
,
STX
Harold C. Urschel, Jr., M.D. Joins Aastrom Biosciences' Board of Directors
Oct 20, 2009 07:02 AM |
ASTM
Aastrom Receives Letter From NASDAQ Regarding Continued Non-Compliance With Minimum Bid Price Rule
Oct 07, 2009 02:46 PM |
ASTM
More..
Danville, Ill., Biofuel Facility Earns Key Designation
Jul 13, 2009 12:53 PM |
ASTM
,
REG
Central Illinoisan Spreading the Ethanol Gospel: Heyworth Woman Works With Trade Group on Standards, Transport
Jun 30, 2009 12:52 PM |
ADM
,
ASTM
,
KMP
More..
Aastrom Receives Letter From NASDAQ Regarding Continued Non-Compliance With Minimum Bid Price Rule; Company Meets All Other NASDAQ Capital Market Initial Listing Requirements Other Than the $1.00 Minimum Bid Price Rule; Company Will Request Hearing to Present Plans for Regaining Compliance; Company to Remain Listed On NASDAQ Capital Market During Hearing Process
Oct 07, 2009 04:11 PM |
ASTM
SmallCapSentinel.com: Bone Marrow Stem Cell Company Profile Released
Aug 27, 2009 07:01 AM |
ASTM
,
GERN
,
OSIR
BenchmarkJournal.Com Free Analyst Review for FRPT, WERN, ARRS, ELNK, LBTYA and ASTM
Aug 20, 2009 08:12 AM |
ARRS
,
ASTM
,
ELNK
,
FRPT
,
LBTYA
,
WERN
Compassionate Use Patients in Spain Treated With Adult Stem Cell Therapy Demonstrate Jaw Bone Regeneration Enabling Dental Implants
Aug 10, 2009 09:01 AM |
ASTM
Aastrom Biosciences to Present At BMO Capital Markets Healthcare Conference
Aug 03, 2009 03:00 PM |
ASTM
InvestorSoup.Com Issues Investment Report for Geron Corp.
Jul 21, 2009 07:57 AM |
ASTM
,
GERN
,
KOOL
Aastrom Biosciences Receives Notification That NASDAQ to Continue Temporary Suspension of Certain Continued Listing Requirements; Aastrom Has Until October 1, 2009 to Regain Compliance
Jul 14, 2009 04:15 PM |
ASTM
Aastrom Biosciences Receives Notification That NASDAQ to Continue Temporary Suspension of Certain Continued Listing Requirements
Jul 14, 2009 03:30 PM |
ASTM
FDA Removes Clinical Hold From Aastrom Phase II IMPACT-DCM Clinical Trial
Jun 18, 2009 06:50 AM |
ASTM
Aastrom Proactively Places Phase II IMPACT-DCM Clinical Trial On Hold Following Report of Serious Adverse Event
May 22, 2009 06:55 AM |
ASTM
More..
Form 4 AASTROM BIOSCIENCES INC For: Oct 16 Filed by: Urschel Harold C Jr (10K)
Oct 20, 2009 10:52 AM
Form 3 AASTROM BIOSCIENCES INC For: Oct 14 Filed by: Urschel Harold C Jr (10K)
Oct 20, 2009 10:50 AM
Form 4 AASTROM BIOSCIENCES INC For: Oct 31 Filed by: DUNBAR GEORGE W JR (10K)
Nov 04, 2008 04:34 PM
Form 4 AASTROM BIOSCIENCES INC For: Oct 17 Filed by: SIMS NELSON M (10K)
Oct 21, 2008 05:58 PM
Form 4 MAYLEBEN TIMOTHY M For: Oct 17 (10K)
Oct 21, 2008 05:54 PM
Form 4 AASTROM BIOSCIENCES INC For: Oct 17 Filed by: SUDOVAR STEPHEN (10K)
Oct 21, 2008 05:54 PM
Form 4 AASTROM BIOSCIENCES INC For: Oct 17 Filed by: Rubino Alan L (10K)
Oct 21, 2008 05:54 PM
Form 4 AASTROM BIOSCIENCES INC For: Oct 17 Filed by: ZERBE ROBERT L MD (10K)
Oct 21, 2008 05:51 PM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
ASTM
Compare to S&P
YTD
-32.04 %
-43.86 %
4 Weeks
-5.58 %
-6.09 %
12 Weeks
-24.51 %
-29.16 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
33.33 %
EPS Growth in Last Year:
33.33 %
Sales Growth in Last Quarter:
5.80 %
Sales Growth in Last Quarter:
170.37 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
